Daily BriefsHealthcare

Daily Brief Health Care: Ainos , Fagron, Max Healthcare Institute and more

In today’s briefing:

  • AIMD: Deep Dive into AI-Powered Smell in Semi Fabs and Robotics After Recent Partnerships
  • What’s New(s) in Amsterdam – 10 April (Fagron)
  • Max Healthcare (MAXHEALTH IN): Multi-Pronged Expansion Strategy Augurs Well for Sustainable Growth


AIMD: Deep Dive into AI-Powered Smell in Semi Fabs and Robotics After Recent Partnerships

By Water Tower Research

  • AI Nose for healthcare, industrials, and robotics. Ainos is digitizing smell with AI Nose to capture airborne chemical signatures, using AI-powered processes to immediately classify and identify scents in any environment.
  • Initially focused on healthcare, Ainos is developing a women’s health test, Ainos Flora with AI Nose, in addition to an elderly care project with Japanese partners to assist caregivers in monitoring seniors.
  • Ainos recently entered partnerships with ugo and ASE, expanding AI Nose development to robotics and industrial applications.

What’s New(s) in Amsterdam – 10 April (Fagron)

By The IDEA!

  • organic revenue CAGR at CER: high single digit to low double digits                       
  • REBITDA margin: approx. 21.0% by 2027, with a progressive increase through 2030 
  • Operating Cash Flow conversion: ≥70% 

Max Healthcare (MAXHEALTH IN): Multi-Pronged Expansion Strategy Augurs Well for Sustainable Growth

By Tina Banerjee

  • Max Healthcare Institute (MAXHEALT IN) completed the acquisition of Jaypee Healthcare in last November, thereby adding 700 beds. Jaypee added INR1,120M revenue with an operating EBITDA of INR230M in Q3FY25.
  • Max is setting up ~500 bedded hospital at Thane, Maharashtra on an asset-light built-to-suit basis. The proposed construction of hospital premises is expected to be completed by 2028.
  • Current expansion plan indicates significant capacity ramp-up (20%+) in FY26, and majority of which will come by Q1, thereby generating scope for revenue realization for most part of the year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars